Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Lebwohl

Cutis

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Cutis|December 7, 2002
Vitamin D and topical therapyMark Lebwohl
Cutis|August 21, 2008
A new standardized method of evaluating cutaneous irritation from topical medicationsAnnemarie Uliasz, Mark Lebwohl
Cutis|July 28, 2006
Impaired skin barrier function in dermatologic disease and repair with moisturizationMark Lebwohl, Lisa G Herrmann
Cutis|December 25, 2007
The evolving role of topical treatments in adjunctive therapy for moderate to severe plaque psoriasisMark Lebwohl, Luz E Colón
Cutis|June 25, 2019
Adult-onset asymmetrical lipomatosisXinyi Yang, Megan Rogge, Mark Lebwohl
Cutis|July 15, 2006
Calcinosis cutis in a patient with eosinophilia-myalgia syndrome: case reportElizabeth Smith, Marsha Gordon, Mark Lebwohl
Cutis|June 18, 2013
Reduced burning and stinging associated with topical application of lactic acid 10% with strontium versus ammonium lactate 12%Madelaine Haddican, Matthew Gagliotti, Mark Lebwohl
Cutis|May 19, 2009
Calcitriol ointment 3 microg/g is safe and effective over 52 weeks for the treatment of mild to moderate plaque psoriasisMark Lebwohl, Jean-Paul Ortonne, Philippe Andres, et al.
Cutis|August 1, 2008
A single-center, double-blind, randomized trial of the atrophogenic effects of fluocinonide cream 0.1% versus clobetasol propionate cream 0.05% in participants with corticosteroid-responsive dermatosesAnnemarie Uliasz, Joshua Zeichner, Jennifer Soung, et al.
Cutis|February 12, 2015
Reduced degree of irritation during a second cycle of ingenol mebutate gel 0.015% for the treatment of actinic keratosisShelbi C Jim On, Madelaine Haddican, Alex Yaroshinsky, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cutis|December 7, 2002
Vitamin D and topical therapyMark Lebwohl
Cutis|August 21, 2008
A new standardized method of evaluating cutaneous irritation from topical medicationsAnnemarie Uliasz, Mark Lebwohl
Cutis|July 28, 2006
Impaired skin barrier function in dermatologic disease and repair with moisturizationMark Lebwohl, Lisa G Herrmann
Cutis|December 25, 2007
The evolving role of topical treatments in adjunctive therapy for moderate to severe plaque psoriasisMark Lebwohl, Luz E Colón
Cutis|June 25, 2019
Adult-onset asymmetrical lipomatosisXinyi Yang, Megan Rogge, Mark Lebwohl
Cutis|July 15, 2006
Calcinosis cutis in a patient with eosinophilia-myalgia syndrome: case reportElizabeth Smith, Marsha Gordon, Mark Lebwohl
Cutis|June 18, 2013
Reduced burning and stinging associated with topical application of lactic acid 10% with strontium versus ammonium lactate 12%Madelaine Haddican, Matthew Gagliotti, Mark Lebwohl
Cutis|May 19, 2009
Calcitriol ointment 3 microg/g is safe and effective over 52 weeks for the treatment of mild to moderate plaque psoriasisMark Lebwohl, Jean-Paul Ortonne, Philippe Andres, et al.
Cutis|August 1, 2008
A single-center, double-blind, randomized trial of the atrophogenic effects of fluocinonide cream 0.1% versus clobetasol propionate cream 0.05% in participants with corticosteroid-responsive dermatosesAnnemarie Uliasz, Joshua Zeichner, Jennifer Soung, et al.
Cutis|February 12, 2015
Reduced degree of irritation during a second cycle of ingenol mebutate gel 0.015% for the treatment of actinic keratosisShelbi C Jim On, Madelaine Haddican, Alex Yaroshinsky, et al.
Pageof 2